Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Caremark Rx To Replace Medco As Mail-Order Provider For Blues Federal Employee Program

This article was originally published in The Pink Sheet Daily

Executive Summary

Blue Cross/Blue Shield Association decision is a strong endorsement of the Caremark/PCS merger – and may lead to more questions about a pending False Claims Act suit against Medco. The change is effective Jan. 1, 2005.

You may also be interested in...



Medco Hopes To Maintain Mail-Service Rx Volume In 2005

Medco hopes to hang on to its current level of mail order prescription volume in 2005 despite the upcoming loss of the Federal Employees Program mail service contract

Chloroquine ‘Approval’ For COVID-19 And The US FDA’s New Reality

Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.

Topics

UsernamePublicRestriction

Register

PS058614

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel